Diabetic nephropathy, usually preceded by hypertension and persistent albuminuria, eventually develops in 30 to 50 % of patients with insulin-dependent (IDDM) or non-insulin-dependent (NIDDM) diabetes mellitus, and is one of the leading causes of end-stage renal failure in most industrialized countries. Based on the finding that both diabetic nephropathy [1] and hypertension [2] tend to cluster in families, it is anticipated that genetic markers can be identified which could allow the early detection of diabetic individuals prone to the development of this devastating complication.The renin-angiotensin system plays a central role in blood pressure regulation and renal function not only as a key regulator of sodium homeostasis, but also as a modulator of vascular tone and possibly vascular structure [3]. These effects are primarily mediated by angiotensin II which is liberated from angiotensinogen (AGT) by the sequential action of renin Diabetologia (1997) 40: 193-199 Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension Summary Recent studies have suggested an association between a deletion (D) variant of the angiotensin-converting-enzyme (ACE) gene and diabetic nephropathy. However, this finding has not been confirmed by all investigators. Furthermore, an M235T variant of the angiotensinogen (AGT) gene has been associated with hypertension, an important risk factor for the development and progression of diabetic nephropathy. The objective of our study was therefore to examine the relationship between these genetic variants of the renin-angiotensin system and diabetic nephropathy and hypertension, respectively, in a large (n = 661) group of Caucasian patients with insulin-dependent (n = 360) or non-insulin-dependent (n = 301) diabetes mellitus. The study had a power of 0.8 to detect a doubling of risk of nephropathy or hypertension in patients with the ACE-DD or AGT-235TT genotype, respectively. Allelic frequencies of the ACE-D and AGT-235T alleles were similar between patients with and without nephropathy in either type of diabetes, and accordingly, there was no significant association between diabetic nephropathy and the ACE or AGT genotype. Likewise, there was no significant association between the ACE or AGT genotype and hypertension. Thus, our data, in this large and ethnically homogeneous group of patients, do not support the hypothesis that these genetic variants of the renin-angiotensin system are strongly associated with either nephropathy or hypertension in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. These genetic markers are therefore unlikely to serve as clinically useful predictors of either nephropathy or hypertension in Caucasian patients with diabetes. [Diabetologia (1997) 40: 193-199]